Literature DB >> 18342792

Allogeneic hematopoietic stem cell transplantation for peripheral T cell lymphomas; evidence of graft-versus-T cell lymphoma effect.

Mehdi Hamadani, Farrukh T Awan, Patrick Elder, Thomas S Lin, Peirluigi Porcu, Kristie A Blum, Steven M Devine.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18342792     DOI： 10.1016/j.bbmt.2008.01.002

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN： 1083-8791            Impact factor:   5.742


× No keyword cloud information.
  13 in total

1.  The role of autologous stem cell transplantation in peripheral T cell lymphoma: a long-term follow-up single-center experience.

Authors:  Malte Roerden; Juliane S Walz; Martin R Müller; Martin Sökler; Birgit Federmann; Lothar Kanz; Wolfgang Bethge; Wichard Vogel
Journal:  J Cancer Res Clin Oncol       Date:  2019-08-13       Impact factor: 4.553

Review 2.  Is myeloablative dose intensity necessary in allogeneic hematopoietic cell transplantation for lymphomas?

Authors:  M A Kharfan-Dabaja; N El-Jurdi; E Ayala; A S Kanate; B N Savani; M Hamadani
Journal:  Bone Marrow Transplant       Date:  2017-04-03       Impact factor: 5.483

3.  Allogeneic hematopoietic cell transplant for peripheral T-cell non-Hodgkin lymphoma results in long-term disease control.

Authors:  Jasmine Zain; Joycelynne M Palmer; Maria Delioukina; Sandra Thomas; Ni-Chun Tsai; Auayporn Nademanee; Leslie Popplewell; Karl Gaal; David Senitzer; Neil Kogut; Margaret O'Donnell; Stephen J Forman
Journal:  Leuk Lymphoma       Date:  2011-06-24

4.  NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  David L Porter; Edwin P Alyea; Joseph H Antin; Marcos DeLima; Eli Estey; J H Frederik Falkenburg; Nancy Hardy; Nicolaus Kroeger; Jose Leis; John Levine; David G Maloney; Karl Peggs; Jacob M Rowe; Alan S Wayne; Sergio Giralt; Michael R Bishop; Koen van Besien
Journal:  Biol Blood Marrow Transplant       Date:  2010-08-10       Impact factor: 5.742

5.  Outcomes of related donor HLA-identical or HLA-haploidentical allogeneic blood or marrow transplantation for peripheral T cell lymphoma.

Authors:  Jennifer A Kanakry; Yvette L Kasamon; Christopher D Gocke; Hua-Ling Tsai; Janice Davis-Sproul; Nilanjan Ghosh; Heather Symons; Javier Bolaños-Meade; Douglas E Gladstone; Lode J Swinnen; Leo Luznik; Ephraim J Fuchs; Richard J Jones; Richard F Ambinder
Journal:  Biol Blood Marrow Transplant       Date:  2013-01-29       Impact factor: 5.742

Review 6.  Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T-cell lymphoma.

Authors:  Max Schlaak; Juliane Pickenhain; Sebastian Theurich; Nicole Skoetz; Michael von Bergwelt-Baildon; Peter Kurschat
Journal:  Cochrane Database Syst Rev       Date:  2013-08-29

7.  A new prognostic score comprising lactate dehydrogenase, albumin and neutrophil to lymphocyte ratio to predict sensitivity to first-line chemotherapy in patients with peripheral T-cell lymphomas.

Authors:  Satoshi Kaito; Yusuke Kanemasa; Yuki Sasaki; Toshihiro Okuya; Tsukasa Yamaguchi; Chikako Funasaka; Tatsu Shimoyama; Yasushi Omuro; Tsunekazu Hishima; Yoshiharu Maeda
Journal:  Int J Hematol       Date:  2017-11-04       Impact factor: 2.490

8.  Impact of autologous and allogeneic stem cell transplantation in peripheral T-cell lymphomas.

Authors:  Peter Reimer
Journal:  Adv Hematol       Date:  2010-12-21

9.  Reduced-intensity allogeneic hematopoietic cell transplantation using fludarabine-melphalan conditioning for treatment of mature T-cell lymphomas.

Authors:  M Delioukina; J Zain; J M Palmer; N Tsai; S Thomas; S Forman
Journal:  Bone Marrow Transplant       Date:  2011-02-28       Impact factor: 5.483

10.  Impact of conditioning regimen intensity on the outcomes of peripheral T-cell lymphoma, anaplastic large cell lymphoma and angioimmunoblastic T-cell lymphoma patients undergoing allogeneic transplant.

Authors:  Malvi Savani; Kwang W Ahn; Yue Chen; Sairah Ahmed; Amanda F Cashen; Mazyar Shadman; Dipenkumar Modi; Farhad Khimani; Corey S Cutler; Jasmine Zain; Jonathan E Brammer; Andrew R Rezvani; Timothy S Fenske; Craig S Sauter; Mohamed A Kharfan-Dabaja; Alex F Herrera; Mehdi Hamadani
Journal:  Br J Haematol       Date:  2022-02-02       Impact factor: 8.615
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.